Replies to post #2415 on Momenta Pharmaceuticals, Inc. (MNTA)

[jbog]

vin,

I guess I must missing something with the theory that you and 10nis are explaining. One year ago, Momenta was trading in the $15 dollar range, same as it is today.

Using that metric, I'd have to say that not only has Momenta's shareholders not benefited from Momenta improved financial performance but we missed out in benefiting from the 18% gain in the general markets.